A comprehensive profiling of soluble immune checkpoints from the sera of patients with non‐small cell lung cancer

BACKGROUND: Immunotherapy was widely used for the treatment of non‐small cell lung cancer (NSCLC). However, whether inhibition of immune checkpoints individually or simultaneously could improve the therapeutic efficacy of NSCLC remains to be investigated. Here, we explored the aberrant levels of sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Ying, Zhang, Chen, Rui, Zhilian, Tang, Weiming, Xu, Yan, Tao, Xiaoxin, Zhao, Qi, Tong, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841185/
https://www.ncbi.nlm.nih.gov/pubmed/35019173
http://dx.doi.org/10.1002/jcla.24224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841185/
https://www.ncbi.nlm.nih.gov/pubmed/35019173
http://dx.doi.org/10.1002/jcla.24224

Ejemplares similares